CBR-DIGOXIN ANTISERUM— 510(k) K780498
Substantially EquivalentClinical Bioresearch
FDA 510(k) clearance K780498 for CBR-DIGOXIN ANTISERUM, Substantially Equivalent on 1978-04-05. Applicant: Clinical Bioresearch.
Clearance details
- Applicant
- Clinical Bioresearch
- Product code
- Code DKA
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.